Albemarle (NYSE: ALB) reported Q2 EPS of $1.09, $0.09 better than the analyst estimate of $1.00. Revenue for the quarter came in at $669.3 million versus the consensus estimate of $859.94 million.

GUIDANCE:

Albemarle sees FY2016 EPS of $3.35-$3.60, versus the consensus of $4.11.

For earnings history and earnings-related data on Albemarle (ALB) click here.